THC Therapeutics, Inc. — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

$0

Net Income/Loss (FY2024)

-$811.6K

Total Assets (FY2024)

$10.6K

Total Equity (FY2024)

-$3.8M

Cash Flows from Operating Activities (FY2024)

-$183.3K

Source: THC Therapeutics, Inc. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.